Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Meningioma 2Neuroblastoma 1Ganglioneuroma 1Ganglioneuroblastoma 1

Interventions

Magnetic Resonance Spectroscopy 281Specimen Handling 271pembrolizumab 253Cyclophosphamide 235Radiotherapy 227Nivolumab 184Cisplatin 172Biopsy 161Carboplatin 155Radiosurgery 143fludarabine 131Blood Specimen Collection 129Surveys and Questionnaires 120Gemcitabine 119Paclitaxel 116venetoclax 114Standard of Care 112Dexamethasone 107Bevacizumab 93Radiation 92Rituximab 91Oxaliplatin 89Cytarabine 88Ipilimumab 84Drug Therapy 84Capecitabine 84Doxorubicin 81durvalumab 80fludarabine phosphate 73Fluorouracil 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Ga(III)-DOTATOC × 90 days × Clear all
NCT07150806 2026-05-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2 Recruiting
30 enrolled
CNS

Meningioma

NCT04082520 2026-04-22

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Mayo Clinic

Phase 2 Recruiting
42 enrolled
CNS

Meningioma

NCT04040088 2026-03-31

An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors

Mayo Clinic

Phase EARLY_PHASE1 Active not recruiting
20 enrolled
CNS

Ganglioneuroma, Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡